MannKind says FDA delays decision on inhaled insulin treatment
(Reuters) - MannKind Corp said the U.S. Food and Drug Administration extended the review date of its inhaled insulin treatment by three months, sendin...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/7YP-jT4QCKY/story01.htm
No comments:
Post a Comment